aparoscopic or open distal gastrectomy after neoadjuvant chemotherapy of docetaxel / S-1 / cisplatin or S-1 / cisplatin for operable gastric cancer, a randomized phase II trial
Phase 2
- Conditions
- gastric cancer
- Registration Number
- JPRN-UMIN000006379
- Lead Sponsor
- non-profit organization KSATTS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
i.Past history of upper-abdominal surgery ii.Past history of surgery for the gastrointestinal tract iii.Body mass index exceeding 30 kg/m2.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Three-year overall survival rate Treatment-related death
- Secondary Outcome Measures
Name Time Method overall survival overall survival after 1st endollment surgical morbidity and mortality, R0 resection rate, R0R1 resection rate, conversion rate, efficacy and safety in patients who complete the surgery efficacy and safety in each subset.